Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | IFNAR1 | P17181 | 1/20 | 0.30 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | FYN | P06241 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL653427 | 0.84 | IFNAR1 (0.42) | ALDH1A1MEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL16581496 | 0.81 | IFNAR1 (0.44) | ALDH1A1MEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL30143555 | 0.80 | ALDH1A1 (0.44) | ALDH1A1KDM4EGAAMEN1MAPT | |
| SCHEMBL2942873 | 0.80 | ALDH1A1 (0.44) | ALDH1A1KDM4EGAAMEN1MAPT | |
| SCHEMBL12079030 | 0.79 | TRPM4 (0.38) | ALDH1A1KDM4EMEN1MAPTKMT2A | |
| SCHEMBL29180165 | 0.73 | ALDH1A1 (0.34) | ALDH1A1KDM4EGAAMEN1MAPT | |
| SCHEMBL3062936 | 0.73 | KDM4E (0.42) | ALDH1A1KDM4EGAAMEN1MAPT | |
| SCHEMBL1395162 | 0.72 | ALDH1A1 (0.44) | ALDH1A1KDM4EGAAMEN1MAPT | |
| SCHEMBL11148330 | 0.72 | MAP2K2 (0.41) | ALDH1A1KDM4EMAPTKMT2ASMN1; SMN2 | |
| SCHEMBL2423602 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012156500-A1 | SEMICONDUCTING COMPOUND FOR GAS SENSING | Université Libre de Bruxelles (BE) | 2012-11-22 | — | — | WO | claimed |
| US-20240215579-A1 | USE OF ANTI-CLOTTING COMPOUNDS AS RODENTICIDES | GULBA DIETRICH (DE) | 2024-07-04 | — | — | US | disclosed |
| EP-4319556-A1 | USE OF ANTI-CLOTTING COMPOUNDS AS RODENTICIDES | Gulba, Dietrich (DE) | 2024-02-14 | — | — | EP | disclosed |
| US-11702541-B2 | Vesicular system and uses thereof | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2023-07-18 | — | — | US | disclosed |
| US-11678659-B2 | Use as rodenticides of compounds that inhibit blood coagulation | GULBA DIETRICH (DE) | 2023-06-20 | — | — | US | disclosed |
| US-10724903-B2 | Polymer encapsulated particles as surface enhanced Raman scattering probes | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2020-07-28 | — | — | US | disclosed |
| US-10464811-B2 | Method of forming a particulate porous metal oxide or metalloid oxide | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2019-11-05 | — | — | US | disclosed |
| US-20190322864-A1 | VESICULAR SYSTEM AND USES THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2019-10-24 | — | — | US | disclosed |
| US-10364350-B2 | Vesicular system and uses thereof | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2019-07-30 | — | — | US | disclosed |
| US-10350172-B2 | Stimuli-responsive interpolymer complex coated hollow silica vesicles | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2019-07-16 | — | — | US | disclosed |
| EP-1874780-A1 | 4-PIPERAZINYLTHIENO[2,3-D]PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | Pharmacia & Upjohn Company LLC (US) | 2008-01-09 | — | — | EP | disclosed |
| EP-1869051-A1 | 4-PIPERAZINYLTHIENO Ý2,3-D¨PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | Pharmacia & Upjohn Company LLC (US) | 2007-12-26 | — | — | EP | disclosed |
| EP-1866317-A1 | 4-PIPERAZINOTHIENO [2, 3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | Pharmacia & Upjohn Company LLC (US) | 2007-12-19 | — | — | EP | disclosed |
| EP-1844052-A1 | THIENO[2,3-D]PYRIMIDINE COMPOUNDS AS INHIBITORS OF ADP-MEDIATED PLATELETS AGGREGATION | Pharmacia & Upjohn Company LLC (US) | 2007-10-17 | — | — | EP | disclosed |
| WO-2007097719-A1 | CYCLISATION PROCESS OF FORMING A MULTIPLE RING COMPOUND | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2007-08-30 | — | — | WO | disclosed |
| WO-2006103544-A2 | 4-PIPERAZINYLTHIENO [2, 3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006103555-A1 | 4-PIPERAZINOTHIENO [2, 3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006103545-A1 | 4-PIPERAZINYLTHIENO [2,3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006100591-A1 | 4-PIPERAZINNYLTHIENO [2,3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2006-09-28 | — | — | WO | disclosed |
| WO-2006079916-A1 | THIENO [2,3-D] PYRIMIDINE COMPOUNDS AS INHIBITORS OF ADP-MEDIATED PLATELETS AGGREGATION | PHARMACIA & UPJOHN COMPANY LLC (US) | 2006-08-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10350172-B2 | Stimuli-responsive interpolymer complex coated hollow silica vesicles | CD44, NSF, SUMO3 | ALDH1A1 4611/4885KDM4E 3518/4885GAA 2618/4885 |
| US-11678659-B2 | Use as rodenticides of compounds that inhibit blood coagulation | PLAT, F2R, PLAUR | ALDH1A1 1602/4885KDM4E 4698/4885GAA 1541/4885 |
| US-20240215579-A1 | USE OF ANTI-CLOTTING COMPOUNDS AS RODENTICIDES | PLG, F13B, F2 | ALDH1A1 1878/4885KDM4E 3055/4885GAA 521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.